pantoprazole has been researched along with Shock, Septic in 1 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kofoed, A | 1 |
| Perner, A | 1 |
| Marker, S | 1 |
| Haase, N | 1 |
| Holst, LB | 1 |
| Møller, MH | 1 |
1 trial available for pantoprazole and Shock, Septic
| Article | Year |
|---|---|
Effects of simulated sample sizes on the mortality effect estimates in three randomized intensive care unit trials.
Topics: Anti-Ulcer Agents; Computer Simulation; Critical Care; Denmark; Female; Finland; Gastrointestinal He | 2020 |